Comparative Study of Hypoglycemic Activity of Cr-Gliclazide and Its β-Cyclodextrin Inclusion Complex
- 1Quaid-e-Azam University , , ,
- 2Forman Christian College (A Chartered University) , , Zahoor Elahi Road, Gulberg III , ,
- 3Kinnaird College for Women , , 93 Jail Road , ,
Abstract
This study investigated the synthesis and pharmacological properties of chromium metal complexes with sulfonylureas (hypoglycemic agents). In these complexes, the structural element (chromium) is held within the cavity of the β-cyclodextrin (βCD) molecule. Conditions were optimized for the inclusion complex: 1:1 host–guest ratio, pH = 12, and temperature: ∼25 °C. Cr(III)-Gliclazide (GCZ) and βCD under appropriate experimental conditions show circular dichroism (CD) bands in the visible region: positive Cotton bands at 24,691 cm–1 (Δε = 20.103 degree L mol–1 cm–1) and 16,666 cm–1 (Δε = 26.6 × 10–3 degree L mol–1 cm–1) and a strong negative Cotton band at 19,230 cm–1 (Aε = 38.1 × 10–3 degree L mol–1 cm–1). The synthesized complexes were assessed for their hypoglycemic activity in rabbits with alloxan-induced diabetes. Cr(III)-GCZ showed an early therapeutic response that persisted over an extended duration, while the Cr(III)-GCZ-βCD inclusion complex showed a delayed therapeutic response but maintained an extended duration of activity compared with the reference (parent) drug, gliclazide (GCZ). The synthesized complexes exhibited good therapeutic potential, and the toxicity of these complexes was found to be quite low (high LD50 values).
Related
- Production and Characterization of β-Cyclodextrin Inclusion Complexes Containing Conjugated Linoleic Acid from Njangsa (Ricinodendron heudelotii) Seed Oil
- Comparative antifungal activity of plant- and microbe-mediated silver nanoparticles against Fusarium oxysporum f. sp. cubense
- Molecular recognition of Atrazine, 2,4-Dichlorophenoxyacetic acid, and Chlorpyrifos by cyclodextrin-based adsorbents: insights into selective pesticide removal
- Can Molecular Docking Predict Guest Orientation in β-Cyclodextrin? A Cross-Docking and DFT Refinement Study
- Lysozyme-Functionalized PVA/CMC/β-Cyclodextrin/Pectin Hydrogel Films for Strawberry Preservation and Flexible Sensing
BibTeX
@article{rasheed2026comparative,
title = {{Comparative Study of Hypoglycemic Activity of Cr-Gliclazide and Its β-Cyclodextrin Inclusion Complex}},
author = {Khalid Rasheed and Christy Munir and Anum Hayat and Amna Yousaf and Faryal Chaudhry and Meerab Fatima},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c09131},
url = {https://pubs.acs.org/acsodf/article/11/41/64097/5444252/Comparative-Study-of-Hypoglycemic-Activity-of-Cr},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative Study of Hypoglycemic Activity of Cr-Gliclazide and Its β-Cyclodextrin Inclusion Complex
AU - Khalid Rasheed
AU - Christy Munir
AU - Anum Hayat
AU - Amna Yousaf
AU - Faryal Chaudhry
AU - Meerab Fatima
PY - 2026
DA - 2026/10/03
JO - ACS Omega
DO - 10.1021/acsomega.6c09131
UR - https://pubs.acs.org/acsodf/article/11/41/64097/5444252/Comparative-Study-of-Hypoglycemic-Activity-of-Cr
AB - This study investigated the synthesis and pharmacological properties of chromium metal complexes with sulfonylureas (hypoglycemic agents). In these complexes, the structural element (chromium) is held within the cavity of the β-cyclodextrin (βCD) molecule. Conditions were optimized for the inclusion complex: 1:1 host–guest ratio, pH = 12, and temperature: ∼25 °C. Cr(III)-Gliclazide (GCZ) and βCD under appropriate experimental conditions show circular dichroism (CD) bands in the visible region: positive Cotton bands at 24,691 cm–1 (Δε = 20.103 degree L mol–1 cm–1) and 16,666 cm–1 (Δε = 26.6 × 10–3 degree L mol–1 cm–1) and a strong negative Cotton band at 19,230 cm–1 (Aε = 38.1 × 10–3 degree L mol–1 cm–1). The synthesized complexes were assessed for their hypoglycemic activity in rabbits with alloxan-induced diabetes. Cr(III)-GCZ showed an early therapeutic response that persisted over an extended duration, while the Cr(III)-GCZ-βCD inclusion complex showed a delayed therapeutic response but maintained an extended duration of activity compared with the reference (parent) drug, gliclazide (GCZ). The synthesized complexes exhibited good therapeutic potential, and the toxicity of these complexes was found to be quite low (high LD50 values).
SN - 2470-1343
ER -